[Pirenzepina as an inhibitor of gastric secretion (experimental research)].
Experimental research has shown that pirenzepina possesses interesting inhibiting properties with respect to gastric secretion and the formation of experimentally induced gastric ulcers.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001570:Benzodiazepinones / Q000494:pharmacology*; D002319:Cardiovascular System / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology*; D010890:Pirenzepine; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced*
D001570:Benzodiazepinones; D010879:Piperazines; D010890:Pirenzepine; D001285:Atropine
La pirenzepina farmaco inibitore della secrezione gastrica.